/PRNewswire/ Jiangsu Recbio Technology Co., Ltd. (the "Company", together with its subsidiaries, the "Group") is pleased to announce that positive results.
/PRNewswire/ (the "Company", together with its subsidiaries, the "Group") on voluntary basis. The board of directors of the Company (the "Board") is pleased.
/PRNewswire/ Jiangsu Recbio Technology Co., Ltd. (the "Company", together with its subsidiaries, the "Group") is pleased to announce that positive results.
/PRNewswire/ Jiangsu Recbio Technology Co., Ltd. (the "Company", together with its subsidiaries, the "Group") is pleased to announce that, the Group has.
/PRNewswire/ Recbio (HKEK:02179), an innovative vaccine company, released its interim result for the fiscal year 2022 in the evening of August 25. During.